Back to top

No $400B Mega Merger? AstraZeneca Rises, Bristol Myers Falls as Report Denies Deal

Shares in British pharma giant AstraZeneca ($AZN) jumped about 5% on Wednesday morning while those in top U.S. biopharma company Bristol Myers ($BM...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AstraZeneca PLC (AZN)

Bristol Myers Squibb Company (BMY)